Redinbo; Matthew R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Redinbo; Matthew R..The latest application filed is for "phenoxy thiophene sulfonamides and other compounds for use as inhibitors of bacterial glucuronidase".

Company Profile

2.9.11

Redinbo; Matthew R. - Chapel Hill NC
REDINBO; MATTHEW R. - DURHAM NC
Redinbo, Matthew R. - Carrboro NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors of microbial beta-glucuronidase enzymes and uses thereof Grant 11,339,178 - Redinbo , et al. May 24, 2	2022-05-24
Phenoxy Thiophene Sulfonamides And Other Compounds For Use As Inhibitors Of Bacterial Glucuronidase App 20210087163 - WILLIAMS; ALFRED L. ; et al.	2021-03-25
Inhibitors Of Microbial Beta-glucuronidase Enzymes And Uses Thereof App 20200010479 - REDINBO; MATTHEW R. ; et al.	2020-01-09
Inhibitors Of Microbial Beta-glucuronidase Enzymes And Uses Thereof App 20190330237 - Redinbo; Matthew R. ; et al.	2019-10-31
Composition and method for inhibiting tumor cell growth Grant 9,492,510 - Potter , et al. November 15, 2	2016-11-15
Phenoxy Thiophene Sulfonamides And Other Compounds For Use As Inhibitors Of Bacterial Glucuronidase App 20160237058 - WILLIAMS; ALFRED L. ; et al.	2016-08-18
Selective .beta.-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents Grant 9,334,288 - Redinbo May 10, 2	2016-05-10
Method for sensitizing tumor cells to chemotherapeutic prodrug CPT-11 Grant 9,068,174 - Potter , et al. June 30, 2	2015-06-30
Composition And Method For Inhibiting Tumor Cell Growth App 20150157696 - Potter; Philip M. ; et al.	2015-06-11
Selective Beta-glucuronidase Inhibitors As A Treatment For Side Effects Of Camptothecin Antineoplastic Agents App 20150051205 - Redinbo; Matthew R.	2015-02-19
Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents Grant 8,557,808 - Redinbo , et al. October 15, 2	2013-10-15
Selective Beta-glucuronidase Inhibitors As A Treatment For Side Effects Of Camptothecin Antineoplastic Agents App 20120322797 - Redinbo; Matthew R. ; et al.	2012-12-20
Compositions For Treating Bacterial Infections App 20120142108 - Potter; Philip M. ; et al.	2012-06-07
Compositions and methods for inducing or inhibiting activities of selected human cells Grant 8,124,393 - Potter , et al. February 28, 2	2012-02-28
Compositions for treating bacterial infections App 20110165141 - Potter; Philip M. ; et al.	2011-07-07
Compositions and methods for inducing or inhibiting activities of selected human cells Grant 7,906,637 - Potter , et al. March 15, 2	2011-03-15
Relaxase Modulators and Methods of Using Same App 20090221530 - Redinbo; Matthew R. ; et al.	2009-09-03
Crystallized mammalian carboxylesterase polypeptide and screening methods employing same App 20030235811 - Redinbo, Matthew R. ; et al.	2003-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.